What the Science Says About PT-141 While large-scale long-term studies on PT-141 synergies are emerging, evidence for its standalone use is strong, particularly in phase 3 trials for HSDD
Manji, H
Does Microdosing a GLP-1 Lead to Weight Loss
Statements Author contributions JW: Writingreview and editing, Conceptualization, Data curation, Investigation, Validation, Writingoriginal draft
GLP-1R causes a reduction in hepatic steatosis and inflammation and increases fat metabolism mediated by increasing hepatic insulin sensitivity [52,53,54]
Were global leaders in NAD+ research With 70,000+ NAD+ users supported and multiple peer-reviewed clinical trials, our in-house Stanford PhD-led Research Team is setting the benchmark for research-driven, clinician-guided NAD+ protocols